KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EBT (2016 - 2025)

Quest Diagnostics (DGX) has disclosed EBT for 17 consecutive years, with $330.0 million as the latest value for Q4 2025.

  • Quarterly EBT rose 10.37% to $330.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 billion through Dec 2025, up 12.17% year-over-year, with the annual reading at $1.3 billion for FY2025, 12.17% up from the prior year.
  • EBT hit $330.0 million in Q4 2025 for Quest Diagnostics, up from $328.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $817.0 million in Q2 2021 to a low of $109.0 million in Q4 2022.
  • Historically, EBT has averaged $372.8 million across 5 years, with a median of $320.0 million in 2022.
  • Biggest five-year swings in EBT: soared 430.51% in 2021 and later crashed 78.29% in 2022.
  • Year by year, EBT stood at $502.0 million in 2021, then plummeted by 78.29% to $109.0 million in 2022, then soared by 117.43% to $237.0 million in 2023, then increased by 26.16% to $299.0 million in 2024, then grew by 10.37% to $330.0 million in 2025.
  • Business Quant data shows EBT for DGX at $330.0 million in Q4 2025, $328.0 million in Q3 2025, and $384.0 million in Q2 2025.